# Prothrombin Times Outside the Therapeutic Range in Otherwise Stable Patients

> **NCT00814177** · PHASE2 · COMPLETED · sponsor: **Hamilton Health Sciences Corporation** · enrollment: 160 (actual)

## Conditions studied

- Atrial Fibrillation
- Venous Thromboembolism
- Ischemic Stroke
- Myocardial Infarction

## Interventions

- **DRUG:** warfarin
- **DRUG:** warfarin

## Key facts

- **NCT ID:** NCT00814177
- **Lead sponsor:** Hamilton Health Sciences Corporation
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-07
- **Primary completion:** 2009-01
- **Final completion:** 2009-04
- **Target enrollment:** 160 (ACTUAL)
- **Last updated:** 2012-08-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00814177

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00814177, "Prothrombin Times Outside the Therapeutic Range in Otherwise Stable Patients". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00814177. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*